Journal article · 2020 · Open access

Cancer statistics, 2020

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal

CA A Cancer Journal for Clinicians, 70(1), 7–30 · Published 1 January 2020 · DOI 10.3322/caac.21590

Open PDFView at the publisherCite this paper

In brief

“Cancer statistics, 2020” is a 2020 journal article by Rebecca L. Siegel and 2 co-authors, published in CA A Cancer Journal for Clinicians. OpenAlex counts 24,101 citations as of 20 November 2026. It is open access: the full text is free to read at CA A Cancer Journal for Clinicians.

Citations
24,101
Most cited in
2021 (7,640)
Field-weighted impact
1752.02
References
76
Authors
3

Abstract

Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on population-based cancer occurrence. Incidence data (through 2016) were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data (through 2017) were collected by the National Center for Health Statistics. In 2020, 1,806,590 new cancer cases and 606,520 cancer deaths are projected to occur in the United States. The cancer death rate rose until 1991, then fell continuously through 2017, resulting in an overall decline of 29% that translates into an estimated 2.9 million fewer cancer deaths than would have occurred if peak rates had persisted. This progress is driven by long-term declines in death rates for the 4 leading cancers (lung, colorectal, breast, prostate); however, over the past decade (2008-2017), reductions slowed for female breast and colorectal cancers, and halted for prostate cancer. In contrast, declines accelerated for lung cancer, from 3% annually during 2008 through 2013 to 5% during 2013 through 2017 in men and from 2% to almost 4% in women, spurring the largest ever single-year drop in overall cancer mortality of 2.2% from 2016 to 2017. Yet lung cancer still caused more deaths in 2017 than breast, prostate, colorectal, and brain cancers combined. Recent mortality declines were also dramatic for melanoma of the skin in the wake of US Food and Drug Administration approval of new therapies for metastatic disease, escalating to 7% annually during 2013 through 2017 from 1% during 2006 through 2010 in men and women aged 50 to 64 years and from 2% to 3% in those aged 20 to 49 years; annual declines of 5% to 6% in individuals aged 65 years and older are particularly striking because rates in this age group were increasing prior to 2013. It is also notable that long-term rapid increases in liver cancer mortality have attenuated in women and stabilized in men. In summary, slowing momentum for some cancers amenable to early detection is juxtaposed with notable gains for other common cancers.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Siegel, R. L., Miller, K. D., & Jemal, A. (2020). Cancer statistics, 2020. CA A Cancer Journal for Clinicians, 70(1), 7–30. https://doi.org/10.3322/caac.21590

MLA 9

Siegel, Rebecca L., et al. “Cancer statistics, 2020.” CA A Cancer Journal for Clinicians, vol. 70, no. 1, 2020, pp. 7–30. https://doi.org/10.3322/caac.21590.

Chicago

Siegel, Rebecca L., Kimberly D. Miller, and Ahmedin Jemal. 2020. “Cancer statistics, 2020.” CA A Cancer Journal for Clinicians 70 (1): 7–30. https://doi.org/10.3322/caac.21590.

Harvard

Siegel, R. L., Miller, K. D. and Jemal, A. (2020) ‘Cancer statistics, 2020’, CA A Cancer Journal for Clinicians, 70(1), pp. 7–30. doi:10.3322/caac.21590.

IEEE

R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2020,” CA A Cancer Journal for Clinicians, vol. 70, no. 1, pp. 7–30, 2020, doi: 10.3322/caac.21590.

BibTeX

@article{siegel2020cancer,
  title     = {{Cancer statistics, 2020}},
  author    = {Siegel, Rebecca L. and Miller, Kimberly D. and Jemal, Ahmedin},
  journal   = {CA A Cancer Journal for Clinicians},
  year      = {2020},
  volume    = {70},
  number    = {1},
  pages     = {7--30},
  doi       = {10.3322/caac.21590},
  url       = {https://doi.org/10.3322/caac.21590}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201711
20181515
201988
20203,6503650
20217,6407640
20225,1595159
20232,9242924
20242,1682168
20251,5921592
2026912912

Its field-weighted citation impact is 1752.02: it has been cited 1752.02 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening

  • cancer incidence
  • cancer mortality
  • lung cancer mortality
  • colorectal cancer
  • breast cancer
  • prostate cancer
  • melanoma
  • liver cancer

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Siegel, R. L., Miller, K. D., & Jemal, A. (2020). Cancer statistics, 2020. CA A Cancer Journal for Clinicians, 70(1), 7–30. https://doi.org/10.3322/caac.21590

How many times has this paper been cited?

24,101 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at CA A Cancer Journal for Clinicians: sign in and open the PDF from this page.

Who wrote this paper?

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal.

What is the DOI of this paper?

10.3322/caac.21590, permanently at https://doi.org/10.3322/caac.21590. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.